A risk score for no reflow in patients with ST-segment elevation myocardial infarction after primary percutaneous

Jin-Wen Wang1, Zi-Qiang Zhou, Yun-Dai Chen

  • 1Beijing Institute of Heart, Lung and Blood Vessel Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.

Clinical Cardiology
|April 21, 2015
PubMed

Insights

A new 7-item risk score accurately predicts no-reflow (NRF) in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). This simplified score aids in early clinical assessment and risk stratification.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Risk Prediction

Background:

  • The no-reflow (NRF) phenomenon complicates ST-segment elevation myocardial infarction (STEMI) treatment.
  • Factors like glucose, age, and thrombus burden influence NRF.
  • Accurate prediction of NRF is crucial for optimal patient management.

Purpose of the Study:

  • To develop a simple, accurate scoring system for predicting NRF risk.
  • To identify key clinical and procedural predictors of NRF in STEMI patients undergoing primary PCI.

Main Methods:

  • A risk score was developed using a training dataset (n=912) and validated on a separate test dataset (n=864).
  • Independent predictors of NRF were identified through multivariable analysis.
  • Receiver operating characteristic (ROC) analysis was employed to assess the score's discriminative ability.

Main Results:

  • Seven significant predictors of NRF were identified: age, pain-to-PCI time, neutrophil count, admission glucose, pre-PCI thrombus score, collateral circulation, and Killip class.
  • A 7-item simplified risk score was constructed using these variables.
  • The risk score demonstrated good predictive performance in the test dataset, with a c-statistic of 0.800.

Conclusions:

  • A simplified 7-item risk score can predict the incidence of NRF in STEMI patients undergoing primary PCI with acceptable accuracy.
  • This score offers a valuable tool for early risk stratification and clinical decision-making.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.8K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
493
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
468